Conversely, ALT may have been overestimated in studies where it is assumed that any tumor that is TA- must be ALT, not taking into account DN cancers and/or the possibility of false-negative results caused by inhibitors of Taq polymerase that confound qTRAP analysis of tumor tissue42. This evidence concerns the gene GPT and cancer.